Icon

Lumify (OTC) - (0.025% Ophthalmic Solution)

Brimondinie Tartrate BAUSCH AND LOMB INC
0.025% Ophthalmic Solution
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
None
Indicated for Ocular redness. The use of Lumify (brimonidine tartrate) ophthalmic solution is for the relief of redness of the eye due to minor eye irritations.
Yes
* **** ** *** ***** *** ***** ** * *** *******. ** *** **, **** ******** ****** ******** ****** *** **** ***** *** **** ** ****** ** * ******. ** **** **, **** ****** *** **** **** ******** ****** ** ******* '*** *** '*** (*** ******** ** **** **, ****). ********'* **** *** **** ******** ** ** ***** ** ******.
Lumify (OTC) Patent 1 Patent 2 Patent 3 Patent 4
******** ****** **** ** **** **, **** ******** *** ** *** **** ** *** **, **** **** ** *** **, **** (***** ******)
***** ******* ****** ********* ******* *** ********* (***** ******)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******** ****** *** / ********* *** **, **** ******* ******** *** ****** *** ****
***** ** / ** *** **, **** ******* **** ******* *** **** *** *** ****
  1. *** **, **** : * **** ** *** ***** *** ***** ** * *** *******.
  2. *** **, **** : ******** ****** ******** ****** *** **** ***** *** **** ** ****** ** * ******.
  3. *** **, **** : ****** *** **** **** ******** ****** ** ******* '*** *** '*** (*** ******** ** **** **, ****)
  4. *** **, **** : ***** ******** ****** *** **** ***** *** **** ** ******.
  5. *** *, **** : ****** *** **** **** ***** **** ****** '*** *** '***.
  6. *** **, **** : ****** *** **** **** * ******** *** ** *** ******** **** ****** '***. ** ****** **** ** ** ****** ** ********.
  7. *** *, **** : ****** *** **** ***** ******* **** ******* ***** *** ******** **** ************ ** ***** ****** ****** '*** (*** **, ****)
  8. *** **, **** : ****** *** **** *** ***** ******* ********* ********** ********* ****** '***.
  9. *** *, **** : ****** *** **** *** ***** ******* ********** **** ******* *****.
  10. *** *, **** : ****** *** **** ***** ******* **** ******* ******** **** ************ ** ***** ****** *** ** ****** '***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.